Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2009-014344-11Phase 2Completed
Phase 2, randomised trial of xenon in hypoxic-ischemic encephalopathy (HIE) and asphyxia neonatorum (2 arms), sponsored by Imperial College London. Primary endpoint: Primary neuroimaging endpoint. Started Mar 2010; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on 2009-014344-11.